UVA1 Phototherapy in Acral Vitiligo

Not Applicable

Completed

• Conditions: Acral Vitiligo

• Registration Number: NCT03378011
• Lead Sponsor: Cairo University

Brief Summary

evaluate the effect of UVA1 phototherapy in the treatment of acral vitiligo.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11
• Primary Completion: 2016-11
• Study Completion: 2016-11
• Status Verified: 2017-12
• Study First Submitted: 2017-12-08
• Study First Submitted QC: 2017-12-17
• Last Update Submitted: 2017-12-17
• Study First Posted: 2017-12-19
• Last Update Posted: 2017-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients with acral vitiligo.
• Patients more than 12 years old.

Exclusion Criteria

• Patients less than 12 years old.
• Patients with any other skin diseases or autoimmune diseases.
• Patients taking medical treatment or phototherapy for vitiligo.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo	1 year	effect of medium dose UVA1 phototherapy in treatment of acral vitiligo using point counting and vitiligo area severity index (VASI) score

Trial Locations

Locations (1)

Maha Fathy Elmasry; 🇪🇬 Cairo, Egypt